United States · FDA National Drug Code directory
Ibandronate sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-575_f38ea198-a3dd-aef9-b467-56ecfef1bc39
- Product NDC
- 55111-575
- Form
- TABLET
- Composition / generic term
- Ibandronate sodium
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120621
- Source listing expiry
- 20271231
Source-listed ingredients
- IBANDRONATE SODIUM — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (55111-575-03) / 1 TABLET in 1 BLISTER PACK (55111-575-11) · 55111-575-03
- 1 BLISTER PACK in 1 CARTON (55111-575-43) / 3 TABLET in 1 BLISTER PACK (55111-575-13) · 55111-575-43
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →